Cargando...
A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment
Despite the development of effective therapies, a substantial proportion of asthmatics continue to have uncontrolled symptoms, airflow limitation, and exacerbations. Transient receptor potential cation channel member A1 (TRPA1) agonists are elevated in human asthmatic airways, and in rodents, TRPA1...
Guardado en:
| Publicado en: | J Exp Med |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Rockefeller University Press
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7918756/ https://ncbi.nlm.nih.gov/pubmed/33620419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20201637 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|